Basit öğe kaydını göster

The association of vascular endothelial growth factor, metalloproteinases and their tissue inhibitors with cardiovascular risk factors in the metabolic syndrome

dc.contributor.authorGelisgen, R.
dc.contributor.authorErdenen, F.
dc.contributor.authorTabak, O.
dc.contributor.authorErman, H.
dc.contributor.authorCengiz, M.
dc.contributor.authorUzun, Hafize
dc.date.accessioned2021-03-03T18:01:07Z
dc.date.available2021-03-03T18:01:07Z
dc.date.issued2016
dc.identifier.citationErman H., Gelisgen R., Cengiz M., Tabak O., Erdenen F., Uzun H., "The association of vascular endothelial growth factor, metalloproteinases and their tissue inhibitors with cardiovascular risk factors in the metabolic syndrome", EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.20, sa.6, ss.1015-1022, 2016
dc.identifier.issn1128-3602
dc.identifier.othervv_1032021
dc.identifier.otherav_4cc5cd03-5360-48c9-bee7-c82b99bff2b2
dc.identifier.urihttp://hdl.handle.net/20.500.12627/54955
dc.description.abstractOBJECTIVE: The present study was proposed to examine the matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and vascular endothelial growth factor (VEGF) in patients with metabolic syndrome (MetS), and to compare these parameters with healthy controls. We also compared the possible association of the circulating levels of MMP-2, MMP-9, TIMP-1, TIMP-2, and VEGF with cardiovascular risk factors in patients with MetS. We also compared the possible association of the circulating levels of MMP-2, MMP-9, TIMP-1, TIMP-2, and VEGF with cardiovascular risk factors in patients with MetS.
dc.language.isoeng
dc.subjectTemel Bilimler
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectSağlık Bilimleri
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.titleThe association of vascular endothelial growth factor, metalloproteinases and their tissue inhibitors with cardiovascular risk factors in the metabolic syndrome
dc.typeMakale
dc.relation.journalEUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
dc.contributor.departmentIstanbul Goztepe Training and Research Hospital , ,
dc.identifier.volume20
dc.identifier.issue6
dc.identifier.startpage1015
dc.identifier.endpage1022
dc.contributor.firstauthorID19505


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster